$CNTB

$0.85 +$0.00 (0.33%) Close

$CNTB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 63.0M shares outstanding

Who owns CNTB?

By type of holder

Institutions 21.9% Insiders 0.0% Everyone else 78.1%

Concentration Top 10 holders own 78.2%

James Huang 20.9% · Panacea Venture Healthcare Fund II, L.P. 20.9%

Institutional ownership

21.9%

+1.7 pts vs last qtr

Institutional holders

+14 vs last qtr

Net shares bought

+1.1M

by institutions in Q2 2026

New / sold out

25 / 11

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. NEW +871.7K
Silverarc Capital Management, LLC NEW +545.0K

Biggest sellers in Q2 2026

Ikarian Capital, LLC −850.0K
Millennium Management LLC −430.9K

Who is planning to sell?

Notices of proposed sale, last 12 months

$9.32M

3 notices from 3 people

Shares covered

3.2M

5.00% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Panacea Innovation Limited 10% owner $6M
Wei Zheng 10% stockholder $2.07M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+1.1%

+0.54% a year

Each share's claim on the business

−1.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $15.9M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years3% 1–3 years5% Under 1 year92%

Quarterly turnover

23.2%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting CNTB on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
IC Ikarian Capital, LLC	4.5M	7.21%	−850.0K (−15.8%)	Q4 '25	1.2%
Shares held by quarter Peak holding5.4M (Q1'26) Change over 8 quarters+4.5M Share of the company7.210% Ikarian Capital, LLC's full portfolio →
6C 683 Capital Management, LLC	1.3M	2.04%	+385.0K (+42.8%)	Q1 '26	0.2%
Shares held by quarter Peak holding1.3M (Q2'26) Change over 8 quarters+1.3M Share of the company2.040% 683 Capital Management, LLC's full portfolio →

Ikarian Capital, LLC

4.5M

% of company

7.21%

Change vs last qtr

−850.0K (−15.8%)

Held since

Q4 '25

683 Capital Management, LLC

1.3M

% of company

2.04%

Change vs last qtr

+385.0K (+42.8%)

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Connect Biopharma Holdings Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CNTB on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
NS Nuveen Small Cap Blend Index Fund TIAA-CREF Funds	$39.9K	19.8K	0.03%	0.00%	July 31, 2026
SC Small Cap Index Fund Northern Funds	$19.5K	8.2K	0.01%	0.00%	June 30, 2026

Nuveen Small Cap Blend Index Fund

TIAA-CREF Funds

Position value

$39.9K

% of company

0.03%

% of the fund

0.00%

As of

July 31, 2026

Small Cap Index Fund

Northern Funds

Position value

$19.5K

% of company

0.01%

% of the fund

0.00%

As of

June 30, 2026

8 more funds behind a free account

See every fund holding Connect Biopharma Holdings Ltd and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JH James Huang 5%+ holder 13D · 21.2%	13.2M	20.90%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company20.900% Disclosed stake13D · 21.2% View the 13D/G filing →
PV Panacea Venture Healthcare Fund II, L.P. 5%+ holder 13D · 21.2%	13.2M	20.90%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company20.900% Disclosed stake13D · 21.2% View the 13D/G filing →

James Huang

5%+ holder13D · 21.2%

13.2M

% of company

20.90%

Change vs last qtr

—

Held since

—

Panacea Venture Healthcare Fund II, L.P.

5%+ holder13D · 21.2%

13.2M

% of company

20.90%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Connect Biopharma Holdings Ltd.

Comments